Effect of antioxidants and NMDA antagonists on the density of NMDA binding sites in rat hippocampal slices exposed to hypoxia/reoxygenation

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 25, Issue 1, 2003, Pages 17-25

  Gasparova Kvaltinova, Z ^a   Stolc S ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

3H glutamate binding; Antioxidants; Hippocampus; Hypoxia reoxygenation; NMDA antagonists; Stobadine

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; ANTIOXIDANT; DIZOCILPINE; GLUTAMIC ACID; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; STOBADINE; TROLOX C;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN HYPOXIA; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; REOXYGENATION;

ANIMALS; ANTIOXIDANTS; BINDING SITES; CELL HYPOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MALE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0037219215     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2003.25.1.772543     Document Type: Article

References (40)

1. McCulloch, J. Excitatory amino acid antagonists and their potential for the treatment of ischemic brain damage in man. Br J Clin Pharmacol 1992, 34: 106-14.
2. Beal, M.F. Aging, energy, and oxidative stress in nearodegenerative diseases. Ann Neurol 1995, 38: 357-66.
3. Perez Velazquez, J.L., Frantseva, M.V., Carlen, P.L. In vitro ischemia promotes glutamate-mediated free radical generation and intracellalar calcium accumulation in hippocampal pyramidal neurons. J Neurosci 1997, 17: 9085-94.
4. Diemer, N.H., Valente, E., Bruhn, T., Berg, M., Jorgensen, M.B., Johansen F.F. Glutamate receptor transmission and ischemic nerve cell damage: Evidence for involvement of excitotoxic mechanisms. Prog Brain Res 1993, 96: 105-23.
5. Dugan, L.L., Choi, D.W. Excitotoxicity, free radicals and cell membrane changes. Ann Neurol 1994, 35: S17-21.
6. Ikeda, Y., Long, D.M. The molecular basis of brain injury and brain edema: The role of oxygen free radicals. Neurosurgery 1990, 27: 1-11.
7. Halliwell, B. Oxidants and central nervous system: Some fundamental questions. Acta Neurol Scand 1989, 126: 23-33.
8. Braughler, J.M., Hall, E.D. Central nervous system trauma and stroke. I. Biochemical consideration for oxygen radicals formation and lipid peroxidation. Free Radic Biol Med 1989, 6: 289-301.
9. Siesjö, B.K., Agarth, C.D., Bengsson, F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1989, 1: 165-211.
10. Bullock, R., Zauner, A., Woodward, J., Young, H.F. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 1995, 26: 2187-89.
11. Clark, G.D. and Rothman, S.M. Blockade of excitatory amino acid receptors protect anoxic hippocampal slices. Neuroscience 1987, 21: 665-71.
12. 3H]glutamate binding to human brain membrane preparations. Japan J Pharmacol 1991, 55: 191-196.
13. 3H]glutamate binding sites. Biochem Biophys Res Commun 1988, 153: 510-17.
14. Bruns, R.F., Lawson-Wendling, K., Pugsley, T.A. A rapid filtration assay for soluble receptors using polyethyleneimine-treated filters. Anal Biochem 1983, 132: 74-81.
15. Lipton, S.A., Rosenberg, P. Excitatory amino acids as final common pathway for neurologic disorders. N Engl J Med 1994, 330: 613-619.
16. Štoic, S., Selecká, J. Protective effect of stobadine, a pyridoindole antioxidant, in hypoxia-reoxygenation injury of ganglionic and hippocampal neurotransmission. Mol Chem Neuropathol 1995, 125: 199-212.
17. Vikolinský, R., Štolc, S. Effects of stobadine, melatonin, and other antioxidants on hypoxia/reoxygenation-induced synaptic transmission fililure in rat hippocampal slices. Brain Res 1999, 850: 118-26.
18. Crepel, V., Represa, A., Ben-Ari, Y. Effect of ischemia and intra-amygdaloic kainate injection on the density of NMDA binding sites in the hippocampal CAI region. Eur J Pharmacol 1988, 151: 355-56.
19. Cano, G., Suarez-Roca, H., Bonilla, E. Alterations of excitatory amino acid receptors in the brain of manganese treated mice. Mol Chem Neuropathol 1997, 30: 41-52.
20. Regner, A., Alves, L.B., Chemale, I. et al. Neurochemical characterization of traumatic brain injury in humans. J Neurotrauma 2001, 18: 783-92.
21. Wenk, G.L., Barnes, C.A. Regional changes in the hippocampal density qf AMPA and NMDA receptor across the lifespan of the rat. Brain Res 2000, 885: 1-5.
22. Kvaltínová, Z., Lukovic, L., Štolc, S. Effect of incomplete ischemia and reperfusion of the rat brain on the density and affinity of α-adrenergic binding sites in the cerebral cortex. Prevention of changes by stobadine and vitamin E. Neuropharmacology 1993, 32: 785-91.
23. Horáková, L., Štoic, S., Chromíková, Z., Pekárová, A., Derková, L. Mechanism off hippocampal reoxygenation injury. Treatment with antioxidants. Neuropharmacology 1997, 36: 177-84.
24. Regain, R.F., Jasper, E., Guo, Y., Panter, S.S. The effect of magnesium on oxidative neuronal injury in vitro. J Neurochem 1998, 70: 77-85.
25. Rothman, S.M. Synaptic activity mediates death of hypoxic neurons. Science 1983, 220: 536-37.
26. Said, S.I., Pakbaz, H., Berisha, H.I., Raza, S. NMDA receptor activation: Critical role in oxidant tissue injury. Free Radic Biol Med 2000, 28: 1300-02.
27. Olney, J.W., Farber, N.B. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins and research tools for studying schizophrenia. Neuropsychopharmacology 1995, 13: 335-45.
28. 14C tracer and product studies. Biochim Biophys Acta 1995, 1237: 77-85.
29. Kagan, V.E., Tsuchiya, M., Serbinova, E., Packer, L., Sies, H. Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem Pharmacol 1993, 45: 393-400.
30. Štolc, S., Bauer, V., Beneš, L., Tichý, M. Medicine with antiarrhythmic and antihypoxic activity and method of its preparation. Czech Patent 1983, 229-67.
31. Beneš, L. and Štolc, S. Stobadine. Drugs Future 1989, 14: 135.
32. Horáková, L., Sies, H., Steenken, S. Antioxidant action of stobadine. Methods Enzymol 1994, 234: 572-80.
33. Horáková, L., Štolc, S. Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen Pharmacol 1998, 30: 627-38.
34. Horáková, L., Uraz, V., Ondrejicková, L., Lukovic, L., Juránek, I. Effect of stobadine on brain lipid peroxidation induced by incomplete ischemia and subsequent reperfusion. Biomed Biochim Acta 1991, 50: 1019-25.
35. Benveniste, H., Drejer, J., Schousbou, A., Diemer, N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984, 43: 1369-74.
36. Szatkowski, M., Attwell, D. Triggering and excution of neuronal death in brain ischemia: Two phases of glutamate release by different mechanisms. Trends Neurosci 1994, 17: 359-65.
37. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1: 623-24.
38. Urushitani, M., Nakamizo, T., Inoue, R. et al. N-methyl-D-aspartate receptor-mediated mitochondrial Ca(2+) overload in acute excitotoxic motor neuron death: A mechanism distinct from chronic neurotoxicity after Ca(2+) influx. J Neurosci Res 2001, 63: 377-87.
39. Babu, N.G., Bawari, M. Single microinjection of L-glutamate induces oxidative stress in discrete regions of rat brain. Biochem Mol Biol International 1997, 43: 1207-17.
40. Kvaltínová, Z., Štolc, S. NMDA binding sites in rat hippocampus under oxidative stress: Effect of antioxidants and NMDA antagonists. Ann NY Acad Sci 1997, 812: 240-42.